Target
Dual specificity mitogen-activated protein kinase kinase 1
Ligand
BDBM50274333
Substrate
n/a
Meas. Tech.
ChEMBL_536668 (CHEMBL995059)
IC50
11±n/a nM
Citation
 Berger, DMDutia, MPowell, DFloyd, MBTorres, NMallon, RWojciechowicz, DKim, SFeldberg, LCollins, KChaudhary, I 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors. Bioorg Med Chem 16:9202-11 (2008) [PubMed]  Article
Target
Name:
Dual specificity mitogen-activated protein kinase kinase 1
Synonyms:
Dual specificity mitogen-activated protein kinase (MEK) | Dual specificity mitogen-activated protein kinase kinase 1 (MEK) | Dual specificity mitogen-activated protein kinase kinase 1 (MEK1) | Dual specificity mitogen-activated protein kinase kinase 1/Mitogen-activated protein kinase 1/RAF proto-oncogene serine/threonine-protein kinase | Dual specificity mitogen-activated protein kinase kinase MEK1/2 | ERK activator kinase 1 | MAP kinase kinase 1 | MAP2K1 | MAPK/ERK kinase 1 | MAPK/ERK kinase 1 (MEK1) | MEK-1 | MEK1 | MP2K1_HUMAN | Mitogen-activated protein kinase 1 (MEK1) | PRKMK1 | VHL-MAP2K1/MAP2K2
Type:
Other Protein Type
Mol. Mass.:
43439.03
Organism:
Homo sapiens (Human)
Description:
Full-length human MEK-1 was generated by PCR and purified as a fusion protein from Escherichia coli lysates.
Residue:
393
Sequence:
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV
  
Inhibitor
Name:
BDBM50274333
Synonyms:
4-({3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl}amino)-7-[(1E)-4-morpholin-4-ylbut-1-enyl]quinoline-3-carbonitrile | CHEMBL485237
Type:
Small organic molecule
Emp. Form.:
C27H25ClN6OS
Mol. Mass.:
517.045
SMILES:
Cn1ccnc1Sc1ccc(Nc2c(cnc3cc(\C=C\CN4CCOCC4)ccc23)C#N)cc1Cl
Structure:
Search PDB for entries with ligand similarity: